Angioimmunoblastic T-cell lymphoma epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Angioimmunoblastic T-cell lymphoma}} {{CMG}}; {{AE}} {{RT}} ==Overview== AILT comprises 15-20% of peripheral T-cell lymphomas and 1-2% of all [[non-Hodgkin ly..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
| Line 11: | Line 13: | ||
==Gender== | ==Gender== | ||
No gender preference for this disease has been observed. | No gender preference for this disease has been observed. | ||
==References== | ==References== | ||
| Line 20: | Line 22: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 18:17, 18 September 2012
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
FDA on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
CDC on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics in the news |
|
Blogs on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [3]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
AILT comprises 15-20% of peripheral T-cell lymphomas and 1-2% of all non-Hodgkin lymphomas.[1]
Age
The typical patient with angioimmunoblastic T-cell lymphoma (AILT) is either middle-aged or elderly.
Gender
No gender preference for this disease has been observed.
References